Movement Alert|Astera Labs Rises 4.96% in Regular Trading, BofA Raises Price Target to $450 Amid Semiconductor Sector Rebound

Market Focus
Jun 25

On June 25, Astera Labs rose 4.96% in regular trading, trading at $407.625/share, with turnover of $198 million.

On the news front, BofA Securities raised its price target on Astera Labs from $240 to $450, representing an 87.5% increase that significantly exceeds the Street consensus target of $267.11, while maintaining a Neutral rating. The dramatic upward revision signals strong conviction in the company's growth trajectory and provides a key valuation anchor for the market.

The stock had previously declined over 8% on June 23 as gains from its inclusion in the Nasdaq 100 index were fully priced in and passive fund forced-buying demand dissipated, triggering concentrated profit-taking. BofA's target price revision has since supported a sustained price recovery. On the same day, BofA also raised targets on Micron Technology and Intel, reflecting broad optimism toward the semiconductor industry.

Within the Semiconductors sector, Micron Technology surged 15.92%, Intel rose 3.81%, and AMD gained 2.89%, providing sector-wide tailwinds that further reinforced the stock's rebound momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10